Publications by authors named "Rukshar Syed"
Background: Neurological disorders are a major global health concern, especially in BRICS nations (Brazil, Russia, India, China, South Africa), where demographic and socio-economic changes have amplified their impact. This study evaluates trends in incidence, prevalence, mortality, and Disability-Adjusted Life Years (DALYs) associated with neurological diseases in these countries from 1990 to 2021, focusing on sex disparities and key risk factors.
Methods: Data were obtained from the Global Burden of Disease (GBD) 2021 database.
Objectives: The objectives of this study were to analyze trends in prostate cancer incidence, incidence, mortality, and disability-adjusted life years (DALYs) from 1990 to 2021 via data from the Global Burden of Disease (GBD) study in South Asia. Additionally, the study projects future prostate cancer incidence rates up to 2031 to inform public health interventions in South Asia.
Methods: Data covering South Asian countries such as Bangladesh, Bhutan, India, Nepal, and Pakistan were obtained from the GBD 2021 portal.
Article Synopsis
- The COVID-19 pandemic has had serious effects on maternal and neonatal health, prompting a systematic review to assess how it influences respiratory distress syndrome (RDS) in newborns from infected mothers.
- The review analyzed 22 studies and found that 11.5% of newborns from COVID-19-positive mothers experienced RDS, with a risk ratio of 2.69 indicating a significantly higher risk compared to newborns from non-infected mothers.
- The findings stress the importance of closely monitoring and managing pregnant women with COVID-19 to reduce potential health issues in their newborns.
Article Synopsis
- E-cigarettes are becoming popular as a way for people to quit smoking, but there are concerns about their use alongside traditional cigarettes, particularly among pregnant women, who may face increased health risks.
- A systematic review analyzed data from 18 studies involving nearly 6 million pregnant women, finding that 4.6% of them reported using both e-cigarettes and traditional tobacco.
- The findings suggest that dual use is a significant health issue, highlighting the need for further research and public health measures to inform and protect pregnant women from the risks of tobacco.
Article Synopsis
- Prostate cancer is a common cancer among men, and this study investigates whether glucagon-like peptide 1 receptor agonists (GLP-1 RAs), usually used for treating type 2 diabetes, can reduce the risk of developing this cancer.
- The research included a systematic review of five studies from various countries, which found that GLP-1 RA use is associated with a significant 28% reduction in prostate cancer risk compared to other treatments.
- The study concludes that GLP-1 RAs could play a role in reducing prostate cancer risk, especially for men with diabetes, but further research is needed to understand how these drugs work in this context and to examine different patient variables.